11.07.2017 • News

Kuwait to Spend $8 Billion on Petchem Projects

(c) Dirk Ercken/Shutterstock
(c) Dirk Ercken/Shutterstock

Kuwait is planning to invest nearly $8 billion into petrochemical projects in Bahrain and other countries over the coming years, according to the Al-Anba newspaper. The projects include new plants as well as expansions of existing facilities owned jointly by Petrochemical Industries Company (PIC).

"PIC is considering many other investment opportunities in several countries…the total costs of the company's projects are expected to exceed $8 billion in the next five years," CEO Mohammed Al-Farhoud, told the Kuwaiti paper.

One project includes a paraxylene plant in Bahrain to be jointly owned by PIC and Bahrain’s state-owned National Oil and Gas Authority. Another is the previously announced 750,000 t/y ethylene glycol plant in Freeport, Texas, US, due for completion in October 2019. A contract for this plant, to be operated by MEGlobal, PIC’s joint venture with Dow Chemical, was signed with Jacobs Engineering last November.

PIC also has plans to build a propylene and plant and a 550,000 t/y PP plant in Alberta, Canada. This project, which was originally announced in April 2016, will proceed as a 50:50 joint venture with Canada’s Pembina Pipeline. The newly formed company, Canada Kuwait Petrochemical Corp. (CKPC), will make a final investment decision on the plant in late 2018.

Al-Farhoud added that another PP plant will be built in South Korea, with a capacity of 400,000 t/y. A study is currently underway with PIC’s joint venture partners.

In January 2016, PIC said it planned to acquire a stake in a joint venture propane dehydrogenation plant in South Korea. The plant, which started operation in 2016 and produces 600,000 t/y propylene, is owned by SK Advanced, which in turn is held 45% by SK Gas, 30% by Advanced Global Investment Company and 25% by PIC.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.